CLYM SCHEDULE 13G/A: SEC filing
An institutional holder
Filed with the SEC on · accession 0000315066-26-002706
CLYM filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 5, 2026. An institutional holder filed an amended Schedule 13G for Climb Bio, Inc. (CLYM), indicating a change in passive ownership position. The stock moved -4.9% by the first close after the filing.
Summary of the filing
An institutional holder filed an amended Schedule 13G for Climb Bio, Inc. (CLYM), indicating a change in passive ownership position. The filing text provided is only the EDGAR directory listing and does not disclose the specific ownership percentage or share count.
Key details
How CLYM stock reacted
Close before
$9.33
Nov 4, 2026
First close after
-4.93%
$8.87
5 trading days
—
Since filing
+10.29%
$10.29
✦ Ask GOAX AI about this filing — what it means for CLYM, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CLYM?
Click hereFrequently asked questions
What did CLYM file with the SEC on Nov 5, 2026?
CLYM filed a SCHEDULE 13G/A (SEC filing). An institutional holder filed an amended Schedule 13G for Climb Bio, Inc. (CLYM), indicating a change in passive ownership position. The filing text provided is only the EDGAR directory listing and does not disclose the specific ownership percentage or share count.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did CLYM stock react to this filing?
CLYM closed at $9.33 before the filing and $8.87 on Nov 5, 2026 (-4.93%).
Other CLYM SEC filings
- 8-K · SEC filingNov 5, 2026
- 10-Q · SEC filingNov 5, 2026
- SCHEDULE 13G · SEC filingOct 28, 2026
- SCHEDULE 13G · SEC filingOct 27, 2026
- 8-K · Fda approvalOct 26, 2026
- 8-K · Fda approvalOct 23, 2026
- 8-K · Fda approvalSep 3, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- 8-K · SEC filingAug 14, 2026
- 8-K · SEC filingAug 6, 2026
Get alerts when CLYM files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days